Maker of Botox Settles Inquiry on Off-Label Marketing - NYTimes.com: "Allergan, the maker of Botox, agreed on Wednesday to pay $600 million to settle charges that it illegally promoted and sold the drug through 2005 for unapproved uses like treating headaches."
Wednesday, September 01, 2010
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment